FOS and breast cancer: In accordance with these findings, in the present study the AGEs, through the cognate receptor RAGE and the subsequent activation of the ROS-ERK1/2-AKT-c-Fos transduction pathway, triggered the expression of IL-8 and its release by the CAFs toward the acquisition of malignant features in the breast cancer cells.